There is an error in Table 4. The Risk ratios for the last row, “Death or stroke” should read as follows: 0.65 (0.58 to 0.73).
Table 4. Baseline characteristics and outcomes in paired-matched population.
| Variable | Statins | Statins plus n-3 PUFA | P value* | |||
|---|---|---|---|---|---|---|
| N | 3,962 | 3,962 | - | |||
| Age, mean (SD) | 65.1 (10.2) | 65.2 (9.9) | 0.29 | |||
| Male sex, n (%) | 2,909 (73.4) | 2,918 (73.6) | 0.828 | |||
| Diabetes, n (%) | 1,094 (27.6) | 1,088 (27.5) | 0.899 | |||
| Hypertension, n (%) | 2,643 (66.7) | 2,673 (67.5) | 0.465 | |||
| Previous MI, n (%) | 194 (4.9) | 184 (4.6) | 0.637 | |||
| Previous CHF, n (%) | 476 (12.0) | 476 (12.0) | 1.00 | |||
| Previous Stroke, n (%) | 69 (1.7) | 63 (1.6) | 0.656 | |||
| Previous AF, n (%) | 209 (5.3) | 219 (5.5) | 0.643 | |||
| Peripheral vascular disease, n (%) | 256 (6.5) | 250 (6.3) | 0.821 | |||
| Previous CABG, n (%) | 36 (0.9) | 37 (0.9) | 1.00 | |||
| Previous PTCA, n (%) | 174 (4.4) | 167 (4.2) | 0.742 | |||
| COPD, n (%) | 402 (10.1) | 395 (10.0) | 0.815 | |||
| Malignancy, n (%) | 88 (2.2) | 93 (2.3) | 0.764 | |||
| Depression, n (%) | 106 (2.7) | 104 (2.6) | 0.944 | |||
| In-hospital complications and procedures | ||||||
| Heart failure, n (%) | 358 (9.0) | 354 (8.9) | 0.906 | |||
| AF, n (%) | 164 (4.1) | 173 (4.4) | 0.650 | |||
| Coronary angiography, n (%) | 1,852 (46.7) | 1,799 (45.4) | 0.240 | |||
| PTCA, n (%) | 834 (21.0) | 844 (21.3) | 0.805 | |||
| CABG, n (%) | 67 (1.7) | 77 (1.9) | 0.447 | |||
| Treatments after discharge | ||||||
| Beta-blockers, n (%) | 3,305 (83.4) | 3,299 (83.3) | 0.869 | |||
| ACEi / ARB, n (%) | 3,539 (89.3) | 3,554 (89.7) | 0.600 | |||
| Clopidogrel, n (%) | 1,714 (43.3) | 1,667 (42.1) | 0.294 | |||
| Aspirin, n (%) | 3,681 (92.9) | 3,666 (92.5) | 0.534 | |||
| Outcomes | ||||||
| Statins | Statins plus n-3 PUFA | Risk ratios (95% CIs) | P value | |||
| All cause death | 539 (13.6%) | 340 (8.6%) | 0.63 (0.56 to 0.72) | <0.001 | ||
| Death or myocardial infarction | 848 (21.4) | 804 (20.3) | 0.95 (0.87 to 1.03) | 0.234 | ||
| Death or atrial fibrillation | 805 (20.3) | 660 (16.7) | 0.82 (0.75 to 0.90) | <0.001 | ||
| Death or CHF | 792 (20.0) | 684 (17.3) | 0.86 (0.79 to 0.95) | 0.002 | ||
| Death or stroke | 662 (16.7) | 456 (11.5) | 0.65 (0.58 to 0.73) | <0.001 | ||
*All p values are for McNemar’s test
Please find the complete, correct Table 4 here:
Reference
- 1. Macchia A, Romero M, D’Ettorre A, Tognoni G, Mariani J (2013) Exploratory Analysis on the Use of Statins with or without n-3 PUFA and Major Events in Patients Discharged for Acute Myocardial Infarction: An Observational Retrospective Study. PLoS ONE 8(5): e62772 doi: 10.1371/journal.pone.0062772 [DOI] [PMC free article] [PubMed] [Google Scholar]